Vital

When the medication isn't working

GLP-1 Not Working First Month: What Is Normal

Little or no weight loss in the first month on a GLP-1 is common, because the starting doses are low by design. Here is what the first weeks are for, what to watch, and when to call your prescriber.

Last reviewed

The Vital angle

Vital logs each dose with its amount, strength, and next dose, and reminders help you keep the same weekly day from the start. Your weight and body trends from Apple Health build up next to the dose history, so by your first check-in you can show the real trend instead of one number.

Four weeks in, the scale has barely moved, and you wonder if your GLP-1 is not working. The first month is the stage where this worry is most common and least likely to mean anything. The starting dose of every major GLP-1 is chosen to help your body adjust, not to produce the results you read about. This guide explains why, what a normal first month can look like, and what is worth raising with your prescriber.

It covers semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®), brand or compounded. It is not medical advice.

The first dose is a starting dose

Both main medications start low and step up slowly:

  • Semaglutide (Wegovy): 0.25 mg once weekly for weeks 1 to 4, then 0.5 mg, 1 mg, and 1.7 mg, each for four weeks, before the usual 2.4 mg maintenance dose from week 17. The label calls the lower doses initiation and escalation doses.
  • Tirzepatide (Zepbound): 2.5 mg once weekly for four weeks, then 5 mg, with further steps of 2.5 mg after at least four weeks on each dose. The label says 2.5 mg is for treatment initiation and is not approved as a maintenance dose.

Both labels give the same reason for the slow climb: it lowers the risk of nausea, vomiting, diarrhea, and other stomach side effects. In other words, month one is built for tolerance. Judging the medication by month one is like judging a training plan by its warm-up.

For more on how the steps work, see dosing schedules.

What a normal first month can look like

People report a wide range in the first four weeks. All of these are common:

  • Noticeably less hunger in the first days after each shot, then a return toward normal by the end of the week.
  • A few pounds lost early, mostly from eating less and some water, then a flat stretch.
  • No real change in appetite or weight at all.
  • Side effects such as mild nausea, fullness, or constipation, with little weight change.

Mayo Clinic's diet program notes that appetite changes can start in the first weeks, and that more weight loss usually follows as the dose increases over the next months. Try not to compare your first month with someone else's. Friends, forums, and social media tend to share the fastest results, and people start at different weights, doses, and products. Your own trend over the next few months is the comparison that counts.

Trial averages show the same slow build. In STEP 1 and SURMOUNT-1, weight loss continued for well over a year, and most of it came after people reached higher doses.

Why the scale can look flat

Even if the medication is working, several things can hide it in the first month:

  1. Daily water swings. Weight moves one to three pounds a day from salt, carbohydrates, hormones, and digestion.
  2. Constipation. Slower digestion is a common early side effect, and it adds weight on the scale. See GLP-1 constipation.
  3. Eating to settle nausea. Some people snack on crackers or bread to calm an uneasy stomach. See GLP-1 nausea relief.
  4. Liquid calories. Juice, sweet coffee drinks, and alcohol are easy to keep taking even when solid food appeal drops.
  5. Starting weight and history. People who already dieted hard before starting often see a slower first month.

Weigh at the same time each morning, and look at the weekly average. A single reading tells you very little.

Check the basics in week one to four

Low results in month one are usually expected, but a few practical problems are worth ruling out early:

  • Pen or syringe technique. Make sure each dose is delivered in full. See injection technique, Ozempic pen not clicking, or Zepbound pen not working.
  • Compounded vial math. If you use a vial, confirm with the pharmacy, in writing, how many syringe units equal your dose. The FDA has received reports of dosing errors from patients who measured the wrong dose.
  • Storage. The medication must stay cold and must not freeze. A shipment that arrived warm needs a call to the pharmacy. See compounded GLP-1 vial storage.
  • Same day each week. A steady weekly day keeps the level more even. See missed GLP-1 dose if you were late.

What to do with the first month

The first month is a good time to set up habits that matter later, while side effects are mild:

  1. Build each meal around protein first, then vegetables. See protein on GLP-1.
  2. Drink water through the day to help with constipation and to prevent dehydration.
  3. Eat smaller meals, and stop at the first sign of fullness.
  4. Start or keep two to three short strength sessions each week.
  5. Record your weight, waist, and how you feel on each day of the dose week.

These habits do not replace the medication. They help you get more from it as the dose rises.

Do not speed up the schedule yourself

It is tempting to take a little more when nothing seems to happen. Do not change, double, or add a dose on your own. A bigger jump raises the risk of severe nausea, vomiting, and dehydration, and the label limits how fast the dose can rise for that reason. If you want to discuss a different pace, ask your prescriber. They may also keep you at a step longer if side effects are hard, which is common.

When to talk to your prescriber

Contact your prescriber or pharmacist if:

  • You still notice no change in appetite after several weeks at your second or third dose step.
  • Side effects make it hard to eat or drink enough.
  • You are unsure whether your doses were delivered fully.
  • You take insulin or a sulfonylurea, because the doses of those medicines may need a change.
  • You use oral birth control and start tirzepatide, because the label advises a non-oral or added barrier method for four weeks after starting and after each dose increase.

If several months pass at a full dose with little change, read semaglutide not working or tirzepatide not working.

When to get care now

Get medical help right away for:

  • Severe stomach pain that does not go away, sometimes spreading to your back, with or without vomiting.
  • Vomiting or diarrhea that stops you from keeping fluids down, or signs of dehydration such as very little urine or dizziness.
  • Swelling of the face, lips, or throat, or trouble breathing.
  • Pain in the upper right stomach, fever, or yellow skin or eyes.

Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Judging the medication by month one

    The Wegovy and Zepbound labels describe the first doses as initiation doses meant to reduce stomach side effects. Most weight loss in trials came months later at higher doses.

  • Taking extra to speed things up

    A faster rise raises the risk of severe nausea, vomiting, and dehydration. Only your prescriber can change the dose or the pace.

  • Reading single weigh-ins

    Water, salt, and constipation can move the scale by several pounds. Weekly averages show the real trend.

  • Snacking to settle nausea

    Crackers, bread, and sweet drinks taken to calm the stomach can offset the early drop in intake. Smaller protein-first meals usually work better.

  • Unchecked compounded vial units

    The FDA has received reports of dosing errors from patients who measured the wrong dose from multi-dose vials. Confirm with the pharmacy how many syringe units equal your dose.

Frequently asked questions

  • Yes. The first month uses a low starting dose meant to help your body adjust. Some people lose a few pounds and some lose none. Most weight loss in trials came later at higher doses.

  • It varies widely. Many people lose a few pounds, partly from eating less and some water, while others see no change. The first month is at 0.25 mg, which the label calls an initiation dose.

  • The Zepbound label says 2.5 mg is for treatment initiation and is not approved as a maintenance dose. The dose usually rises to 5 mg after four weeks, with more steps after that.

  • Do not change your dose on your own. A faster rise raises the risk of severe stomach side effects and dehydration. Ask your prescriber if you want to discuss the pace.

  • Talk to your prescriber if you notice no change in appetite after several weeks at your second or third dose step, or if months pass at a full dose with little weight change.

Sources

  1. Zepbound (tirzepatide) Prescribing Information · Eli Lilly and Company
  2. Wegovy (semaglutide) injection Prescribing Information · U.S. Food and Drug Administration
  3. How fast does semaglutide kick in · Mayo Clinic Diet
  4. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine
  5. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine
  6. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.